Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving viable micro-organism
Patent
1987-02-05
1990-06-26
Rosen, Sam
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving viable micro-organism
435 34, 43524021, 435267, 435268, 435803, 435261, 436 63, 436800, 436813, C12O 124
Patent
active
049371878
ABSTRACT:
Fragments of a biopsy sample on the order of about 50 to 5000 cells are preferred for establishing viable tumor cell cultures for purposes such as establishing cell lines, chemotherapeutic assays and the like. Such fragments retain the three-dimensional cellular structure or organization of the original tumor and, therefore, can be cultured more readily. To obtain such fragments suitable for culturing, the biopsy sample can be enzymatically digested in a proteolytic or nucleolytic enzyme, such as collagenase, or by mechanical dissociation, or both where necessary. The fragments can then be suspended in an aqueous medium so that non-aggregated cells (e.g., red blood cells, lymphocytes, macrophages) and cellular debris will form a supernatant while the remaining fragments containing aggregated tumor cells are deposited in a sediment layer. Preferably, the medium is an isotonic tissue culture medium and decantation is conducted at least twice; first in a serum-containing medium and then, secondly, in a serum-free medium. Fragments containing living tumor cells can be selected by fluorochromasia, that is, by contacting the sedimented layer with a fluorogenic substrate such that viable tumor cells take up and hydrolyse the substrate, and then exhibit fluorescence. Cytotoxicity assay protocols employing tumor cell aggregates prepared by the present techniques are also disclosed.
REFERENCES:
patent: 3073746 (1963-01-01), Thompson et al.
patent: 3586859 (1971-06-01), Katz et al.
patent: 3821087 (1974-06-01), Knazek et al.
patent: 3853712 (1974-12-01), House et al.
patent: 3948732 (1976-04-01), Haddad et al.
patent: 4184922 (1980-01-01), Knazek et al.
patent: 4201845 (1980-05-01), Feder et al.
patent: 4220725 (1980-07-01), Knazek et al.
patent: 4241187 (1980-12-01), White
patent: 4242459 (1980-12-01), Chick et al.
patent: 4308351 (1981-12-01), Leighton et al.
patent: 4332893 (1982-06-01), Rosenberg
patent: 4350768 (1982-09-01), Tihon et al.
patent: 4391912 (1983-07-01), Yoshida et al.
patent: 4423145 (1983-12-01), Stampfer et al.
patent: 4537860 (1985-08-01), Tolbert et al.
patent: 4554251 (1985-11-01), Hink, Jr.
patent: 4559299 (1985-12-01), Rotman
patent: 4582787 (1985-04-01), Frankel
Rotman, Boris & Papermaster, Ben W., "Membrane Properties of Living Mammalian Cells as Studied by Enzymatic Hydrolysis of Fluorogenic Esters", Proceedings of the National Academy of Sciences, vol. 55, No. 1, pp. 134-141, Jan. 1966.
Knazek, Richard A., Fed. Pro., vol. 33, No. 8, 1974, pp. 1978-1981, "Solid Tissue Masses Formed in Vitro From Cells Cultured on Artificial Capillaries".
Salmon, Sydney E. et al., The New England Journal of Medicine, vol. 298, pp. 1321-1327, (Jun. 15, 1978), "Quantitation of Differential Sensivity of Human-Tumor Stem Cells to Anticancer Drugs".
Buick et al., Cancer Research, vol. 39, pp. 5051-5056 (1979), "Development of an Agar-Methyl Cellulose Clonogenic Assay for Cells in Transitional Cell Carcinoma of the Human Bladder".
Von Hoff et al., Cancer, vol. 50, pp. 696-701 (1982), "Direct Cloning of Human Malignant Melanoma in Soft Agar Culture".
Tsuda et al., "Investigation of Factors Involved in the uptake Velocity of Flourescein Diacetate and Intracellular Flouresience Polarization Valve, I. Physiological Aspects in Lymphoblastoid Cells", Cell Structure and Function, vol. 7, pp. 166-175 (1982).
Maeda et al., "Investigation of Factors Involved in the uptake Velocity of Fluorescein Diacetate and Intracellular Fluorescecen Polarization Value II, Cytotoxicity Produced by Anticancer Agents", Cell Structure and Function, vol. 7, pp. 177-182 (1982).
Rotman, "Assessment of Drug Sensitivity in Organ Cultures from Individual Human Biopsies", Proceeding of the American Association for Cancer Research (1985).
Brown University Research Foundation
Engellenner Thomas J.
Rosen Sam
LandOfFree
Methods for separating malignant cells from clinical specimens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for separating malignant cells from clinical specimens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for separating malignant cells from clinical specimens will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1125415